|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| MSR valuation adjustments, net | |||||
| Provision for bad debts (advances and receivables) | |||||
| Provision for (reversal of) representation and warranty obligations | |||||
| Depreciation | |||||
| Amortization of debt discount and issuance costs | |||||
| Amortization of Intangible Assets | |||||
| Loss (gain) on extinguishment of debt | |||||
| Provision for (reversal of) valuation allowance on deferred tax assets | |||||
| Equity-based compensation expense | |||||
| Interest capitalized on reverse buyouts | |||||
| Deferred income tax (benefit) expense | |||||
| Gain on reverse loans and HMBS-related borrowings, net | |||||
| Earnings of equity method investee | |||||
| Net gain on sale of investment in equity method investee | |||||
| Gain on loans held for sale, net | |||||
| Changes in assets and liabilities: | |||||
| Decrease in advances | |||||
| Decrease in receivables and other assets | |||||
| Increase (Decrease) in Derivative Assets and Liabilities | |||||
| Increase (decrease) in other liabilities | |||||
| Origination and purchase of loans held for sale | |||||
| Proceeds from sale and collections of loans held for sale | |||||
| Other, net | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Origination of loans held for investment | |||||
| Principal payments received on loans held for investment | |||||
| Purchase of MSRs | |||||
| Proceeds from sale of MSRs | |||||
| Acquisition of loans held for investment, net | |||||
| Acquisition of reverse mortgage subservicing agreements | |||||
| Distribution of capital from equity method investee | |||||
| Net proceeds from sale of investment in equity method investee | |||||
| Acquisition of advances in connection with MSR transactions | |||||
| Proceeds from sale of advances in connection with MSR transactions | |||||
| Purchase of real estate | |||||
| Proceeds from sale of real estate | |||||
| Additions to premises and equipment | |||||
| Other, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Repayment of advance match funded liabilities, net | |||||
| Proceeds from (repayment of) mortgage warehouse facilities, net | |||||
| Proceeds from reverse mortgage securitization notes | |||||
| Repayment of reverse mortgage securitization notes | |||||
| Proceeds from (repayment of) MSR financing facilities, net | |||||
| Repayment of MSR financing facilities | |||||
| Repurchase and repayment of Senior notes | |||||
| Proceeds from issuance of Senior notes | |||||
| Payment of debt issuance costs | |||||
| Proceeds from other financing liabilities - Sale of MSRs accounted for as secured financing | |||||
| Proceeds from other financing liabilities - Excess Servicing Spread (ESS) liability | |||||
| Proceeds from MSR related financing liabilities | |||||
| Repayment of MSR related financing liabilities | |||||
| Proceeds from sale of HECM or reverse mortgages, accounted for as a financing (HMBS-related borrowings) | |||||
| Repayment of HMBS-related borrowings | |||||
| Issuance of common stock | |||||
| Repurchase of common stock | |||||
| Other, net | |||||
| Proceeds from issuance of preferred stock | |||||
| Payment of preferred stock issuance costs | |||||
| Payment of preferred stock dividend | |||||
| Payment on exercise of common stock warrants | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental cash flow information | |||||
| Interest paid | |||||
| Income tax payments (refunds), net | |||||
| Federal | |||||
| State | |||||
| Foreign | |||||
| Total income tax payments (refunds), net | |||||
| HECM loans held for investment acquired at fair value | |||||
| HMBS-related borrowings assumed at fair value | |||||
| Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset | |||||
| Series B Preferred stock issuance at fair value | |||||
| Other, net | |||||
| Net cash received (paid) on HECM transactions | |||||
| Supplemental non-cash investing and financing activities | |||||
| Right-of-use asset | |||||
| Lease liability | |||||
| Transfer from loans held for investment to loans held for sale | |||||
| Transfers of loans held for sale to real estate owned (REO) | |||||
| Derecognition of MSRs | |||||
| Derecognition of financing liabilities: | |||||
| Restricted cash and equivalents: | |||||
| Cash and cash equivalents | |||||
| Debt service accounts | |||||
| Other restricted cash | |||||
Loading...